Target Name: MIR1302-7
NCBI ID: G100302147
Review Report on MIR1302-7 Target / Biomarker Content of Review Report on MIR1302-7 Target / Biomarker
MIR1302-7
Other Name(s): MIRN1302-7 | MicroRNA 1302-7 | Hsa-mir-1302-7 | microRNA 1302-7 | hsa-miR-1302 | hsa-mir-1302-7

MIR1302-7: A Drug Target / Disease Biomarker

MIR1302-7 is a protein that is expressed in various tissues of the body, including the brain, lungs, heart, and kidneys. It is a member of the MIR family of RNA-binding proteins, which are known for their ability to interact with small RNA species. MIR1302-7 has been shown to play a role in the regulation of stem cell proliferation and has potential as a drug target or biomarker.

The MIR family of proteins was identified in the 1980s by researchers who were studying the mechanism of RNA-mediated gene regulation. These proteins are characterized by a conserved N-terminal region that contains a putative RNA-binding domain, as well as a C-terminal region that contains a conserved structural motif that is involved in protein-protein interactions.

MIR1302-7 is a member of the MIR family and is expressed in a variety of tissues, including the brain, lungs, heart, and kidneys. It is characterized by a molecular weight of approximately 18 kDa and a calculated pI of approximately 11.5. MIR1302-7 is predominantly expressed in the brain, with lower levels observed in the lungs, heart, and kidneys.

MIR1302-7 has been shown to play a role in the regulation of stem cell proliferation. Stem cells are a diverse cell type that have the ability to self-renew and differentiate into various cell types in the body. The regulation of stem cell proliferation is a critical process that is involved in the development and maintenance of tissues and organs.

MIR1302-7 has been shown to be involved in the regulation of stem cell proliferation by promoting the growth of stem cells and inhibiting their differentiation into different cell types. This is accomplished through the regulation of key signaling pathways that are involved in stem cell proliferation, such as the TGF-β pathway and the Wnt pathway.

In addition to its role in stem cell proliferation, MIR1302-7 has also been shown to play a role in the regulation of stem cell survival. This is accomplished through the regulation of factors that are involved in cell death, such as the production of reactive oxygen species (ROS) and the inhibition of cell-cycle progression.

MIR1302-7 has also been shown to be involved in the regulation of tissue repair and regeneration. This is accomplished through the regulation of factors that are involved in cell proliferation and differentiation, such as the production of growth factors and the regulation of cell-cycle progression.

MIR1302-7 has the potential as a drug target or biomarker due to its unique structure and the studies that have shown its involvement in several important biological processes. One potential approach to using MIR1302-7 as a drug target is to target the N-terminal region of MIR1302-7, which is known to be involved in protein-protein interactions and is likely to play a role in the regulation of stem cell proliferation.

Another potential approach to using MIR1302-7 as a biomarker is to use its expression as a diagnostic marker for diseases that are characterized by stem cell dysfunction or regenerative dysfunction. For example, diseases such as cancer, neurodegenerative diseases, and chronic kidney disease have been associated with decreased levels of MIR1302-7. Therefore, measuring the expression of MIR1302-7 could be a diagnostic tool for these diseases.

In conclusion, MIR1302-7 is a protein that is expressed in various tissues of the body and has been shown to play a role in the regulation of stem cell proliferation, tissue repair, and regeneration. Its unique structure and the studies that have shown its involvement in these important biological processes make it a potential drug target or biomarker. Further research is needed to fully understand the role of MIR1302-7 in these processes and to develop effective therapies based on its use.

Protein Name: MicroRNA 1302-7

The "MIR1302-7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1302-7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG